Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The objective of the study is to identify socio-demographic factors, behaviors and practices associated with infection with SARS-CoV-2 to help determine where and how patients mostly get infected with SARS-CoV-2. It is a case-control study including : - cases identified by the nationwide system of positive SARS-CoV-2 tests (COVID-19 diagnosis information system, SIDEP) (currently limited to qRT-PCR) and invited to participate by the National Health Insurance (CNAM) which hosts the data from the nationwide test system; - controls included via Ipsos, a polling institute with access to personal data from a panel from which they will include controls matched on age (divided into 10-year categories), gender and geographic area (departement); - cases will be offered to invite a person they live with to participate in the study offering another case-control analysis inside a household. These participants will be required to report the result of the test as recommended by contact tracing guidelines to determine whether they are cases or controls. Data will be collected via a self-administered online questionnaire. Some of the participants will be called for a complementary telephone questionnaire to measure reliability of online retrieved data and explore more specific aspects of SARS-CoV-2 transmission.
Description: Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places through case-control analyses.
Measure: Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places reported by the participants in the online questionnaire Time: 1 yearDescription: Proportion of cases reporting likely contamination circumstances in the family environment
Measure: Proportion of cases infected in family environment by SARS-CoV-2 reported by participants in the phone interview Time: 1 yearDescription: Proportion of cases reporting likely contamination circumstances in the family environment
Measure: Proportion of cases infected in family environment by SARS-CoV-2 reported by participants in the online questionnaire Time: 1 yearDescription: Proportion of cases reporting likely contamination circumstances in the professional environment
Measure: Proportion of cases infected in professional environment by SARS-CoV-2 reported by participants in the phone interview Time: 1 yearDescription: Proportion of cases reporting likely contamination circumstances in the professional environment
Measure: Proportion of cases infected in professional environment by SARS-CoV-2 reported by participants in the online questionnaire Time: 1 yearDescription: Proportion of participants reporting adherence to mask-wearing
Measure: Level of adherence to mask-wearing reported in the phone interview Time: 1 yearDescription: Proportion of participants reporting adherence to mask-wearing
Measure: Level of adherence to mask-wearing reported in the online questionnaire Time: 1 yearDescription: Proportion of participants reporting adherence to hand-washing
Measure: Level of adherence to hand-washing in the phone interview Time: 1 yearDescription: Proportion of participants reporting adherence to hand-washing
Measure: Level of adherence to hand-washing in the online questionnaire Time: 1 yearDescription: Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places through case-control analyses.
Measure: Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places reported by the participants in the phone interview Time: 1 yearAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports